These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recombinant expression, purification, and kinetic and inhibitor characterisation of human site-1-protease. Bodvard K; Mohlin J; Knecht W Protein Expr Purif; 2007 Feb; 51(2):308-19. PubMed ID: 16973377 [TBL] [Abstract][Full Text] [Related]
3. Novel circular, cyclic and acyclic Ψ(CH(2)O) containing peptide inhibitors of SKI-1/S1P: synthesis, kinetic and biochemical evaluations. Majumdar S; Chen A; Palmer-Smith H; Basak A Curr Med Chem; 2011; 18(18):2770-82. PubMed ID: 21568902 [TBL] [Abstract][Full Text] [Related]
4. Aminoethyl benzenesulfonyl fluoride and its hexapeptide (Ac-VFRSLK) conjugate are both in vitro inhibitors of subtilisin kexin isozyme-1. Basak S; Stewart NA; Chrétien M; Basak A FEBS Lett; 2004 Aug; 573(1-3):186-94. PubMed ID: 15327996 [TBL] [Abstract][Full Text] [Related]
5. Multibranch and pseudopeptide approach for design of novel inhibitors of subtilisin kexin isozyme-1. Basak S; Mohottalage D; Basak A Protein Pept Lett; 2006; 13(9):863-76. PubMed ID: 17100641 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242. Pasquato A; Rochat C; Burri DJ; Pasqual G; de la Torre JC; Kunz S Virology; 2012 Feb; 423(1):14-22. PubMed ID: 22154237 [TBL] [Abstract][Full Text] [Related]
8. The promise of proprotein convertase subtilisin/kexin 9 inhibitors for the treatment of familial hypercholesterolemia. Pokharel Y; Virani SS; Ballantyne CM Curr Atheroscler Rep; 2015 May; 17(5):508. PubMed ID: 25782778 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the prohormone convertase subtilisin-kexin isoenzyme-1 induces apoptosis in human melanoma cells. Weiß N; Stegemann A; Elsayed MAT; Schallreuter KU; Luger TA; Loser K; Metze D; Weishaupt C; Böhm M J Invest Dermatol; 2014 Jan; 134(1):168-175. PubMed ID: 23884247 [TBL] [Abstract][Full Text] [Related]
10. A Molecular Sensor To Characterize Arenavirus Envelope Glycoprotein Cleavage by Subtilisin Kexin Isozyme 1/Site 1 Protease. Oppliger J; da Palma JR; Burri DJ; Bergeron E; Khatib AM; Spiropoulou CF; Pasquato A; Kunz S J Virol; 2016 Jan; 90(2):705-14. PubMed ID: 26512085 [TBL] [Abstract][Full Text] [Related]
11. Zymogen activation and subcellular activity of subtilisin kexin isozyme 1/site 1 protease. da Palma JR; Burri DJ; Oppliger J; Salamina M; Cendron L; de Laureto PP; Seidah NG; Kunz S; Pasquato A J Biol Chem; 2014 Dec; 289(52):35743-56. PubMed ID: 25378398 [TBL] [Abstract][Full Text] [Related]
12. Differential recognition of Old World and New World arenavirus envelope glycoproteins by subtilisin kexin isozyme 1 (SKI-1)/site 1 protease (S1P). Burri DJ; da Palma JR; Seidah NG; Zanotti G; Cendron L; Pasquato A; Kunz S J Virol; 2013 Jun; 87(11):6406-14. PubMed ID: 23536681 [TBL] [Abstract][Full Text] [Related]
13. C(2)-Symmetric azobenzene-amino acid conjugates and their inhibition of Subtilisin Kexin Isozyme-1. Basak A; Mitra D; Das AK; Mohottalage D; Basak A Bioorg Med Chem Lett; 2010 Jul; 20(13):3977-81. PubMed ID: 20605451 [TBL] [Abstract][Full Text] [Related]
14. N-glycosylation controls trafficking, zymogen activation and substrate processing of proprotein convertases PC1/3 and subtilisin kexin isozyme-1. Zandberg WF; Benjannet S; Hamelin J; Pinto BM; Seidah NG Glycobiology; 2011 Oct; 21(10):1290-300. PubMed ID: 21527438 [TBL] [Abstract][Full Text] [Related]
15. Novel reactive site loop derived mini-serpin inhibitors of recombinant proprotein convertase 4. Basak A; Shervani N; Kolajova M; Cherla S; Basak S Adv Exp Med Biol; 2009; 611():105-6. PubMed ID: 19400113 [No Abstract] [Full Text] [Related]
16. The proprotein convertase SKI-1/S1P. In vitro analysis of Lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors. Pasquato A; Pullikotil P; Asselin MC; Vacatello M; Paolillo L; Ghezzo F; Basso F; Di Bello C; Dettin M; Seidah NG J Biol Chem; 2006 Aug; 281(33):23471-81. PubMed ID: 16790437 [TBL] [Abstract][Full Text] [Related]
17. [Cholesterol associated to low density lipoproteins (LDL) and vascular risk reduction. Proprotein convertase subtilisin/kexin type 9 (PCSK9): A new therapeutic target]. Guijarro C; Ruilope LM Med Clin (Barc); 2015 Jul; 145(2):67-9. PubMed ID: 26004275 [No Abstract] [Full Text] [Related]
19. The proprotein convertases are potential targets in the treatment of dyslipidemia. Seidah NG; Prat A J Mol Med (Berl); 2007 Jul; 85(7):685-96. PubMed ID: 17351764 [TBL] [Abstract][Full Text] [Related]
20. The proprotein convertases and their implication in sterol and/or lipid metabolism. Seidah NG; Khatib AM; Prat A Biol Chem; 2006 Jul; 387(7):871-7. PubMed ID: 16913836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]